McKesson Corporation Stock Price and Value Analysis

McKesson Corporation (NYSE:MCK) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold McKesson Corporation to reach your target.

Target type

MCK Free Cash Flow Trend

Free Cash Flow trendline for MCK
Free Cash Flow trendline for McKesson Corporation
CSV

Based on historical returns, we believe that McKesson Corporation can grow its free cash at a rate of about 18%. That's positive!

AdvantagesDisadvantages
  • This company is very stable.
  • This stock is available at a great discount!
  • This company is making money at a great rate!
  • This company has stable growth.
  • This company has a low dividend yield.

Inside the MCK Numbers

MCK Price
(McKesson Corporation stock price per share)
$1069.43
[?] MCK Fair Price
(based on intrinsic value)
$1528.70
[?] MCK Safety Price (based on a variable margin of safety) $1222.96
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 36% higher than other Healthcare stocks
[?] PE Ratio versus Industry 67% lower than other Medical Distribution stocks
[?] Cash Yield 3.29%
[?] Free Cash Flow Jitter 14%
[?] Dividend Yield 0.32% (tax impact)
Shares Shorted 1,990,460

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,990,460 shares shorted. With 115,270,779 shares available for purchase and an average trading volume over the past 10 trading days of 636,550, it would take at least 3.1 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2008 927653 674
2009 927653 1,156
2010 927653 2,120
2011 927653 2,133
2012 927653 2,741
2013 927653 2,265
2014 927653 2,902
2015 927653 2,842
2016 927653 3,351
2017 927653 4,387
2018 927653 3,955
2019 927653 3,590
2020 927653 3,902
2021 927653 4,039
2022 927653 3,905
2023 927653 4,600
2024 927653 3,729
2025 927653 5,429
2026 927653 5,540

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 17 fiscal years from 2009 to 2026 with positive net income, operating cash flow totaled $65,004 million against net income of $32,830 million, or 1.98 times. Net income was negative in 1 of the 18 years, and those years are left out of the ratio.

In 2026, operating cash flow was 1.29 times net income, compared with 1.83 times for the earliest three years (2009 to 2011).

In 2026, capital expenditures were $436 million, 7.1% of operating cash flow of $6,155 million, which leaves an estimated $5,719 million after capex. Across the 18 years with reported capex, it averaged 11.2% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Cash conversion in 2026 was 1.29, at least 0.25 under the 1.83 earliest three-year ratio. Gaps like this come from non-cash gains or from cash tied up in receivables, inventory or other working capital.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2009 823 1,351 195 1.64
2010 1,263 2,316 199 1.83
2011 1,202 2,338 233 1.95
2012 1,403 2,950 221 2.10
2013 1,338 2,483 241 1.86
2014 1,263 3,136 278 2.48
2015 1,476 3,112 376 2.11
2016 2,258 3,672 488 1.63
2017 5,070 4,744 404 0.94
2018 67 4,345 405 64.85
2019 34 4,036 557 118.71
2020 900 4,374 506 4.86
2021 -4,539 4,542 641 n/a
2022 1,114 4,434 535 3.98
2023 3,560 5,159 558 1.45
2024 3,002 4,314 687 1.44
2025 3,295 6,085 859 1.85
2026 4,762 6,155 436 1.29

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2017 to 2026 with dividend or share repurchase facts, estimated free cash flow totaled $43,075 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 10 of those years with dividend payment facts, dividends paid totaled $2,986 million, 6.9% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 10 of those 10 years.

In 10 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $26,410 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2026, dividends and cash spent repurchasing shares together were $5,131 million, 92.6% of estimated free cash flow of $5,540 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2017 4,387 253 2,311 2,564 58.5%
2018 3,955 262 1,709 1,971 49.8%
2019 3,590 292 1,639 1,931 53.8%
2020 3,902 294 1,934 2,228 57.1%
2021 4,039 276 742 1,018 25.2%
2022 3,905 277 3,516 3,793 97.1%
2023 4,600 292 3,638 3,930 85.4%
2024 3,729 314 3,025 3,339 89.6%
2025 5,429 345 3,146 3,491 64.3%
2026 5,540 381 4,750 5,131 92.6%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $101,703 million in 2008 and $403,430 million in 2026, a compound annual growth rate of 8.0% over 18 years.

Revenue rose 12.4% from 2025 to 2026.

Our estimated free cash flow was $5,540 million in 2026, 1.4% of revenue. In 2008 the estimated margin was 0.7%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2008 101,703 674 0.7%
2009 106,632 1,156 1.1%
2010 108,702 2,120 1.9%
2011 112,084 2,133 1.9%
2012 122,321 2,741 2.2%
2013 122,196 2,265 1.9%
2014 137,392 2,902 2.1%
2015 179,045 2,842 1.6%
2016 190,884 3,351 1.8%
2017 198,533 4,387 2.2%
2018 208,357 3,955 1.9%
2019 214,319 3,590 1.7%
2020 231,051 3,902 1.7%
2021 238,228 4,039 1.7%
2022 263,966 3,905 1.5%
2023 276,711 4,600 1.7%
2024 308,951 3,729 1.2%
2025 359,051 5,429 1.5%
2026 403,430 5,540 1.4%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2026, cash and equivalents were $3,975 million against total liabilities of $84,100 million, or 4.7% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 102.2% of total assets in 2026, compared with 75.5% in 2009, an increase of 26.7 percentage points.

Stockholders equity was negative in 2026, at -$1,777 million, which means the company's liabilities and other claims on its assets exceeded the assets themselves. Companies that return cash through large buybacks can show negative equity for that reason alone, but it also leaves no book value cushion for shareholders.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 48.9% in 2026. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2009 25,267 2,109 19,074 6,193
2010 28,189 3,731 20,657 7,532
2011 30,886 3,612 23,666 7,220
2012 33,093 3,149 26,262 6,831
2013 34,786 2,456 27,716 7,070
2014 51,759 4,193 41,441 10,318
2015 53,870 5,341 45,785 8,085
2016 56,523 4,048 47,515 9,008
2017 60,969 2,783 49,696 11,273
2018 60,381 2,672 50,324 10,057
2019 59,672 2,981 51,385 8,287
2020 61,247 4,015 55,938 5,309
2021 65,015 6,278 64,840 175
2022 63,298 3,532 65,090 -1,792
2023 62,320 4,678 63,810 -1,490
2024 67,443 4,583 69,042 -1,599
2025 75,140 5,691 76,834 -1,694
2026 82,323 3,975 84,100 -1,777

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $1,069.43, our model's value equals that price if free cash flow grows an average of 13.7 percent a year over the 10 projection years. Our model assumes 18.5 percent a year for this stock, so the price implies growth of 13.7 percent, which is below the 18.5 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $4,067 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $855.54 10.7%
Current price $1,069.43 13.7%
20 percent above the current price $1,283.32 16.1%
Our model (stored fair price) $1,528.70 18.5%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Free cash flow was positive in all 19 fiscal years we have for McKesson Corporation under its current SEC filer.

At $1069.43, the stock is under our safe value of $1222.96, against a fair value estimate of $1528.70.

Average free cash flow over the last three years of data was $4,899 million, and across the first three years it was $1,317 million; over the period it rose sharply.

Free cash flow is fairly steady from year to year, with a variability measure of 14%.

Its dividend yield is 0.32%.

Before you act on any of this, read what a margin of safety means and check the company's own filings.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 36% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is 67% below the average for stocks in the Medical Distribution industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Medical Distribution industry, the ones closest in market capitalization to McKesson Corporation, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
McKesson Corporation (MCK) 123,473 27.6 0.3% 3.3% 30% below
Henry Schein (HSIC) 9,232 22.9 - 7.3% 44% below
SiteOne Landscape Supply (SITE) 4,646 28.4 - - 180% above
Herbalife Nutrition Ltd. (HLF) 1,629 9.1 - 39.8% 97% below
Nu Skin Enterprises (NUS) 185 - 6.4% 182.1% 98% below

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 927653.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2026
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: MCK annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in MCK

Does McKesson Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: MCK

This example shows how we apply the Trendshare checklist to MCK: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 1069.43
    • Market cap: $123B
    • EPS: 38.77
  2. Step 2 — Valuation checks

    • P/E: 27.584
    • FCF yield: 3.3%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.